Rahul Dhanda
The COVID pandemic has changed the future of CRISPR and synthetic biology, says Rahul Dhanda, Sherlock Biosciences CEO
It’s been a transformative year for synthetic biology and for the world. The COVID-19 pandemic exposed weaknesses in our global ...